SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Paint The Table
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jorj X Mckie who wrote (8020)1/2/2002 4:43:35 PM
From: Libbyt  Read Replies (1) of 23786
 
the important point being that HMOs are not governed by the doctors

You're right...although there has to be a balance of some type of agreement as to the community standard of care in order to keep the HMOs and the physicians working together.

I was able to get one "feedback" answer to your question...and again, you are right that the trend seems to be moving towards HMOs only paying for generic drugs. In our area about half of the HMOs have this "policy" to encourage generic use by their co-pay policies. When using a generic drug a patient may have a $5-10 co-pay, but when requesting a specific drug (that has a generic available) they may be have a $20-40 co-pay if they choose to not use the generic drug.

There still are a few name brand drugs that some physicians feel very strongly about using...such as certain thyroid or seizure medications. Although these drugs are the same as far as generic "make up", the release rate of the desired drug doesn't seem to be the same.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News